191228-98-5

Upstream product

• 191229-04-6 (3S,4R,5R,6S)-N-benzyl-3,6-O-dibenzoyl-4,5-bistetrahydropyranylazepane 
• 191229-05-7 (3S,4R,5R,6S)-N-benzyl-3,6-O-dibenzoyl-4,5-dihydroxyazepane 

Downstream Products

• 191229-01-3 Benzoic acid (2R,3R,4R,5S)-1-benzyl-5-hydroxy-3,4-bis-(tetrahydro-pyran-2-yloxy)-piperidin-2-ylmethyl ester 
• 132198-35-7 (2R,3R,4R,5S)-N-benzyl-2-(benzoyloxymethyl)-3,4,5-tri-O-benzoylpiperidine 
• 191229-02-4 (2R,3R,4R,5S)-N-benzyl-2-(benzoyloxymethyl)-3,4,5-trihydroxypiperidine 
• 191229-06-8 (1S,5R,6R,7R)-3-Benzyl-6,7-bis-(tetrahydro-pyran-2-yloxy)-8-oxa-3-aza-bicyclo[3.2.1]octane 

Relevant academic research and scientific papers

Stereoselective transformations of polyhydroxyazepanes to piperidine and pyrrolidine derivatives - Efficient glycosidase inhibitors

N-Benzyl-4, 5-O-diprotected-3, 6-dihydroxyazepanes 1a and 1b prepared by the reaction of 1, 2 : 5, 6-dianhydro-3, 4-O-isopropylidene-L-iditol and benzylamine undergo a skeletal rearrangement to furnish the piperidine derivatives 3a and 3b under Mitsunobu